More PRNewswire
View Older Stories View Newer Stories-
CLPS Incorporation Unveils Web3-Ready Issuance Platform, Making a Strategic Leap into the Stablecoin Economy
-
Lilly to Acquire Adverum Biotechnologies
-
STANDEX ANNOUNCES TIMING OF FIRST QUARTER FISCAL 2026 RESULTS
-
Actinium Pharmaceuticals Presents New Data Demonstrating Potent and Durable Efficacy of ATNM-400, a First-in-Class Multi-Tumor Actinium-225 Radiotherapy, at the 32nd Annual Prostate Cancer Foundation
-
Vonage Unveils First-of-its-Kind AI and Network Innovation at Dreamforce 2025
-
Maximum Fair Price Strategies for IPAY2027 Readiness, Upcoming Webinar Hosted by Xtalks
-
SAMARITAS OPENS "HOUSE OF INNOVATION" IN DETROIT
-
PNC Executives to Speak at BancAnalysts Association of Boston Conference
-
Marvion Inc. Reports Over 100% Revenue Growth and Commences Construction of New Warehouses in Hong Kong
-
BiomEdit Awarded Nearly $2 Million from Bezos Earth Fund to Advance AI Model for Methane-Reduction Strategies in Cattle
-
Former UN Secretary-General Commends AiMOGA Robotics: When Eastern Courtesy Meets the Intelligent Future
-
The Pepsi National Battle of the Bands Expands to The Palm Beaches for 2026
-
Buffalo Biodiesel Announces $300 Million Growth Partnership with Verite Capital Partners; Don Jones to Become Minority Owner and Chairman
-
RPM Appoints Walt Piekarski as Chief Commercial Officer to Spearhead Next Phase of Strategic Growth and Industry Innovation
-
Introducing The Yankee Candle YC Collection: A New Standard in Home Fragrance Inspired by Quiet Luxury for the Home
-
Consumer Edge Announces Beta Launch of AI-Powered Chat to Transform How Companies Uncover More Insights, Faster
-
ChemDiv Extends Discovery and Early Development Partnership with Mondego Bio on Best-in-Class PTPN2 Immuno-Oncology Program
-
REI Co-op introduces Campwell Collection: Cozy layers for fall life outside
-
Icotrokinra long-term results affirm promise of targeted oral peptide with high rates of durable skin clearance and favorable safety profile in difficult-to-treat scalp and genital psoriasis
-
Orna Therapeutics Announces Encore Presentation at the American College of Rheumatology Annual Meeting Supporting its in vivo CAR Therapy Approach in Autoimmune Diseases
-
HOLDCO ASSET MANAGEMENT RELEASES PRESENTATION PREVIOUSLY PROVIDED TO THE BOARD OF DIRECTORS OF FIRST INTERSTATE BANCSYSTEM, INC. ON SEPTEMBER 3, 2025
-
AAM to Announce Third Quarter Financial Results on November 7
-
Bybit Enhances Capital Mobility for VIP and Institutional Traders with Expanded Withdrawal Limits
-
Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance
-
Neurotronic Announces First Clinical Outcomes of Multi‑Organ Denervation for Type 2 Diabetes and Hypertension
-
Brazilian President Lula Meets XCMG Chairman Yang Dongsheng, Welcoming Further Investment and Innovation
-
Koppers Holdings Inc. Schedules Third Quarter 2025 Conference Call
-
Nigeria's Central Bank Engages Fintech Leaders at IMF-World Bank Meetings
-
ChoiceOne Reports Third Quarter 2025 Results
-
Calumet, Inc. to Release Third Quarter 2025 Earnings on November 7, 2025
-
Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
-
General Dynamics Reports Third-Quarter 2025 Financial Results
-
Jugbow Care Initiative Launches Scholarship at Alula Film Festival, Merging Cinema and Compassionate Action
-
Bybit TradFi Launches Referral Program Offering Up to 30% in Rewards
-
Lufax Announces Change in Chief Risk Officer
-
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
-
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
-
Weekly Recap: 11 Finance Press Releases You Need to See
-
Weekly Recap: 13 Consumer Press Releases You Need to See
-
Trilogy Metals Provides Update on the Issuance of Federal Right-of-Way Permits for the Ambler Access Project in Alaska
-
Weekly Recap: 12 Tech Press Releases You Need to See
-
Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania's Green Future
-
Weekly Recap: 14 Health Press Releases You Need to See
-
13 Press Releases You Need to See This Week
-
FLAGSTAR BANK, N.A. REPORTS THIRD QUARTER 2025 NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.11 PER DILUTED SHARE AND ADJUSTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.07 PER DILUTED SH
-
Sensor Tower secures strategic investment from Shinhan Securities to help fuel product innovation, gen-AI data enhancements
-
America's Most Searched Tacos and Margaritas Are In!
-
West to Participate in Upcoming Investor Conferences
-
VestGen Expands National Platform to Serve Retirement Plan Sponsors
-
Yuchai Launches New Generation High-Horsepower YC16VTF Generator Engine
